Feed HOLX
HO

Hologic HOLX · NASDAQ

$76.01 +0.00% (+$0.00)

Market cap
$17.0B
Enterprise value
$17.6B
P/E
30.6x
Forward P/E
-
PEG
-
P/S
4.1x
P/FCF
18.1x
EV/EBITDA
16.3x
ROIC
7.3%
Bruto marža
53.0%
Neto marža
13.8%
Dividend yield
-
Payout ratio
-
Neto dolg/EBITDA
0.6x
Beta
0.70
Free float
99.1%

O podjetju

Hologic, Inc. (HOLX) is an American company operating in the field of medical technologies and diagnostic solutions. The company specializes in the development, manufacturing, and sale of innovative medical devices and diagnostic tests for women's health. Its products include mammography systems, devices for osteoporosis diagnosis, cytology and molecular diagnostic systems, among others. Hologic holds a strong market position in women's health and is known for its advanced technologies and high-quality diagnostic solutions. The company focuses on providing innovative tools and technologies that enable early detection and diagnosis of diseases, contributing to the improvement of patients' health outcomes. Investors seeking exposure to the healthcare sector and technologies for women's health may consider shares of Hologic, Inc. (HOLX) as an interesting investment opportunity.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

CEO

Paul Malenchini

Employees

7,063

Headquarters

Marlborough

Vrednotenje

Je današnja cena primerna?

Rast in ocene

Ali podjetje raste in kaj sledi?

Donosnost in kakovost

Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?

Finančno zdravje

Ali zmore svoj dolg?

Kapital in dividende

Kaj podjetje počne z zasluženim denarjem?

Analitiki

Kaj menijo strokovnjaki in ali se to spreminja?

Lastniki in insajderji

Kdo ima delnice in kaj počne vodstvo?

Segmenti

Kateri del podjetja raste?

Primerjava s konkurenco

Kako se primerja s podobnimi podjetji?

Cena in tveganje

Kako se delnica obnaša?

Izkazi

Vse številke

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.